Emsam Patch
Product Images NDC 49502-902

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Emsam (NDC 49502-902). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Viatris Specialty Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Selegiline Structural Formula (Image 01)

FDA Label Image

Figure 1: Side View Of Emsam (Image 02)

This is a product specification that describes the composition of a medical adhesive or drug layer that comes with a backing Filr and release liner. No further information is available for the context or the purpose of the product.*

FDA Label Image

Figure 2. Kaplan-meier Estimates Of Cumulative Percent Of Patients With Relapse (study 3) (Image 03)

FDA Label Image

Instructions For Use Figure A (Image 04)

This appears to be a list of body parts.*

FDA Label Image

Instructions For Use Figure C And Figure D (Image 05)

This appears to be a label or packaging description for an adhesive product that is used in conjunction with medicine. The text mentions a backing on the outside of the adhesive, likely on the opposite side from where the medicine would be applied. However, without further context or information, it is difficult to provide a more detailed description or identify the specific product.*

FDA Label Image

Instructions For Use Figure H (Image 06)

FDA Label Image

Instructions For Use Figure E (Image 07)

FDA Label Image

Dosage Application 6 mg/24 H (Image 08)

FDA Label Image

Emsam Transdermal 6 mg/24 Hour Carton Label (Image 09)

FDA Label Image

Dosage Application 9 mg/24 H (Image 10)

The text is not available.*

FDA Label Image

Emsam Transdermal 9 mg/24 Hour Carton Label (Image 11)

This is a product description for Mylan® Selegiline Transdermal System. The product is a prescription-only medication with NDC number 49502-901-30. It comes in a package containing 30 transdermal systems, each releasing 9mg/24h of the active ingredient. The product label warns against eating certain foods and recommends reading the enclosed Medication Guide. The product should only be used for transdermal purposes, and pharmacists should dispense the product with the Medication Guide included. The rest of the text is illegible.*

FDA Label Image

Dosage Application 12 mg/24 H (Image 12)

This text is describing medical adhesive patches designed for application to various parts of the body, including the upper arm, upper chest, and upper thigh. The patches likely contain medication, and there is a release liner that needs to be removed before application.*

FDA Label Image

Instructions For Use Figure B (Image 13)

FDA Label Image

Instructions For Use Figure F (Image 14)

FDA Label Image

Instructions For Use Figure G (Image 15)

FDA Label Image

Emsam Transdermal 12 mg/24 Hour Carton Label (Image 16)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.